Flow-mediated vasoactivity and circulating adhesion molecules in hypertriglyceridemia: association with small, dense LDL cholesterol particles.

BACKGROUND Endothelial dysfunction is considered one of the earliest events in the process of atherosclerosis, and an impaired vasodilatory response has been reported in patients with dyslipidemias. However, the independent association between hypertriglyceridemia and endothelial dysfunction is controversial, and the relation between endothelium-dependent vasodilation and circulating cell adhesion molecules as markers of endothelial dysfunction has not been fully determined. METHODS Brachial artery flow mediated vasodilation (FMV) and the soluble forms of vascular cell adhesion molecule-1 (sVCAM-1) and intercellular adhesion molecule-1 (sICAM-1) were determined after overnight fasting in 16 men with hypertriglyceridemia (age 33 +/- 6 years) and in 16 age-matched healthy men with normal triglycerides and cholesterol. Subjects who smoked and those with known cardiovascular disease, diabetes, hypertension, recent or active infections, or any other disease that could affect leukocyte activation were excluded from the study. RESULTS Compared with normal subjects, subjects with hypertriglyceridemia showed a higher level of sVCAM-1 and sICAM-1 (both P <.001), a reduced FMV (P <.01), and a smaller LDL particle size (P <.05). FMV had a significant inverse correlation with sVCAM-1 (r = -0.61, P <.001) and sICAM-1 (r = -0.38, P <.03). LDL particle size had a strong, direct association with FMV (r = 0.75, P <.001) and an inverse association with adhesion molecules. By multiple regression analysis, triglycerides (P <.001) and small LDL particle size (P <.002) predicted a reduced FMV. CONCLUSIONS Serum level of cell adhesion molecules is increased and FMV is impaired in young healthy men with hypertriglyceridemia compared with age-matched men with normal lipid levels. Small, dense LDL particles may play a role in determining endothelial dysfunction in these subjects.

[1]  R. Krauss,et al.  Identification of multiple subclasses of plasma low density lipoproteins in normal humans. , 1982, Journal of lipid research.

[2]  P. Ganz,et al.  Postischemic vasodilation in human forearm is dependent on endothelium-derived nitric oxide. , 1996, The American journal of physiology.

[3]  A. Yeung,et al.  Endothelium-dependent coronary vasomotion relates to the susceptibility of LDL to oxidation in humans. , 1996, Circulation.

[4]  C. Ballantyne,et al.  Levels of Soluble Cell Adhesion Molecules in Patients With Dyslipidemia , 1996 .

[5]  J. Deanfield,et al.  Passive smoking and impaired endothelium-dependent arterial dilatation in healthy young adults. , 1996, The New England journal of medicine.

[6]  M. Creager,et al.  Hyperhomocyst(e)inemia is associated with impaired endothelium-dependent vasodilation in humans. , 1997, Circulation.

[7]  I. Meredith,et al.  Endothelial vasodilator function is related to low-density lipoprotein particle size and low-density lipoprotein vitamin E content in type 1 diabetes. , 2000, Journal of the American College of Cardiology.

[8]  A. Yeung,et al.  Close relation of endothelial function in the human coronary and peripheral circulations. , 1995, Journal of the American College of Cardiology.

[9]  G. Dagenais,et al.  Small, dense low-density lipoprotein particles as a predictor of the risk of ischemic heart disease in men. Prospective results from the Québec Cardiovascular Study. , 1997, Circulation.

[10]  P. Ganz,et al.  Hypertension and Left Ventricular Hypertrophy Are Associated With Impaired Endothelium‐Mediated Relaxation in Human Coronary Resistance Vessels , 1993, Circulation.

[11]  M W Ramsey,et al.  Endothelium and inelastic arteries: an early marker of vascular dysfunction in non-insulin dependent diabetes , 1996, BMJ.

[12]  A. Malik,et al.  Vascular endothelial adhesion molecules and tissue inflammation. , 1996, Pharmacological reviews.

[13]  R. Levy,et al.  Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. , 1972, Clinical chemistry.

[14]  A. Gearing,et al.  Circulating adhesion molecules in disease. , 1993, Immunology today.

[15]  D. Celermajer,et al.  Endothelial dysfunction: does it matter? Is it reversible? , 1997, Journal of the American College of Cardiology.

[16]  S M Grundy,et al.  Small LDL, atherogenic dyslipidemia, and the metabolic syndrome. , 1997, Circulation.

[17]  A. Dart,et al.  Endothelium-dependent relaxation by acetylcholine is impaired in hypertriglyceridemic humans with normal levels of plasma LDL cholesterol. , 1999, Journal of the American College of Cardiology.

[18]  M. Friedman Pathogenesis of coronary artery disease , 1969 .

[19]  A M Zeiher,et al.  Endothelium-mediated coronary blood flow modulation in humans. Effects of age, atherosclerosis, hypercholesterolemia, and hypertension. , 1993, The Journal of clinical investigation.

[20]  R. de Caterina,et al.  Soluble vascular cell adhesion molecule-1 as a biohumoral correlate of atherosclerosis. , 1997, Arteriosclerosis, thrombosis, and vascular biology.

[21]  E. Boerwinkle,et al.  Circulating adhesion molecules VCAM-1, ICAM-1, and E-selectin in carotid atherosclerosis and incident coronary heart disease cases: the Atherosclerosis Risk In Communities (ARIC) study. , 1997, Circulation.

[22]  J. Hokanson,et al.  Characterization of low‐density lipoprotein subclasses: methodologie approaches and clinical relevance , 1994, Current opinion in lipidology.

[23]  G. Watts,et al.  Impaired endothelium-dependent vasodilation of forearm resistance vessels in hypercholesterolaemia , 1992, The Lancet.

[24]  G. Plotnick,et al.  Effect of a single high-fat meal on endothelial function in healthy subjects. , 1997, The American journal of cardiology.

[25]  G. Plotnick,et al.  Changes in flow-mediated brachial artery vasoactivity with lowering of desirable cholesterol levels in healthy middle-aged men. , 1996, The American journal of cardiology.

[26]  R. Ross,et al.  Atherosclerosis is an inflammatory disease. , 1998, American heart journal.

[27]  R. Vogel Cholesterol lowering and endothelial function. , 1999, The American journal of medicine.

[28]  M. Omata,et al.  Altered myocardial vasodilatation in patients with hypertriglyceridemia in anatomically normal coronary arteries. , 1998, Arteriosclerosis, thrombosis, and vascular biology.

[29]  V. Fuster,et al.  The pathogenesis of coronary artery disease and the acute coronary syndromes (2). , 1992, The New England journal of medicine.

[30]  K. Schenck-Gustafsson,et al.  Transient triglyceridemia decreases vascular reactivity in young, healthy men without risk factors for coronary heart disease. , 1997, Circulation.

[31]  C. Smith,et al.  Soluble cell adhesion molecules in hypertriglyceridemia and potential significance on monocyte adhesion. , 1998, Arteriosclerosis, thrombosis, and vascular biology.

[32]  Bridget Wilcken,et al.  Pathogenesis of coronary artery disease , 1969 .

[33]  G. Watts,et al.  Preserved endothelial function in patients with severe hypertriglyceridemia and low functional lipoprotein lipase activity. , 1997, Journal of the American College of Cardiology.

[34]  A. Baron,et al.  Endothelial dysfunction is associated with cholesterol levels in the high normal range in humans. , 1997, Circulation.

[35]  C. Wanner,et al.  Impairment of endothelium-dependent dilation in rabbit renal arteries by oxidized lipoprotein(a). Role of oxygen-derived radicals. , 1995, Circulation.

[36]  B. Nordestgaard The vascular endothelial barrier — selective retention of lipoproteins , 1996, Current opinion in lipidology.

[37]  D. Playford,et al.  Low‐density lipoprotein size, high‐density lipoprotein concentration, and endothelial dysfunction in non‐insulin‐dependent diabetes , 1997, Diabetic medicine : a journal of the British Diabetic Association.

[38]  G. Plotnick,et al.  Effect of antioxidant vitamins on the transient impairment of endothelium-dependent brachial artery vasoactivity following a single high-fat meal. , 1997, JAMA.